{"id":"W2793122709","doi":"10.1016/j.clinthera.2017.12.015","title":"An Observational Study of Concomitant Use of Emerging Therapies and Denosumab or Zoledronic Acid in Prostate Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Amgen","keywords":"Medicine; Enzalutamide; Denosumab; Cabazitaxel; Prostate cancer; Zoledronic acid; Concomitant; Abiraterone acetate; Internal medicine; Oncology; Docetaxel; Cohort; Population; Cancer; Androgen deprivation therapy; Osteoporosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004608291,0.000109808,0.0004093985,0.00006778679,0.00003820353,0.00001058904,0.00007984561,0.00006385771,0.00006646112],"category_scores_gemma":[0.00005289175,0.00006905657,0.0000404009,0.0002106284,0.000445387,0.0001051216,0.00003618564,0.0001785727,5.845328e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004131283,"about_ca_system_score_gemma":0.0003041934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000103084,"about_ca_topic_score_gemma":0.0004256368,"domain_scores_codex":[0.9985822,0.0001692296,0.0006100791,0.0002192886,0.0002364003,0.000182845],"domain_scores_gemma":[0.9989161,0.000334483,0.0001506277,0.000255785,0.000272438,0.00007053064],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004393618,0.001626161,0.952852,0.00004522382,0.0003773166,0.00001190769,0.004300743,0.000003197118,0.003518934,0.00002954683,0.000009085303,0.03283233],"study_design_scores_gemma":[0.009481184,0.009269141,0.9731295,0.0001594424,0.0001508025,0.000002402949,0.002338555,0.001382815,0.002808098,0.0001413216,0.001032774,0.0001040141],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967572,0.001837715,0.000006772808,0.000565865,0.00009199011,0.0007006449,0.00001890137,0.00001074264,0.00001013368],"genre_scores_gemma":[0.9943534,0.004697807,0.0003743066,0.0002748084,0.00008129708,0.00003087735,0.000006469075,0.00001767728,0.0001633995],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03272831,"threshold_uncertainty_score":0.2816045,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5229752836077713,"score_gpt":0.5422627704409436,"score_spread":0.01928748683317227,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}